Business Segments · Research and development expenses
MedSurg — Research and development expenses
Boston Scientific MedSurg — Research and development expenses decreased by 8.0% to $127M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.0%, from $121M to $127M. Over 3 years (FY 2022 to FY 2025), MedSurg — Research and development expenses shows an upward trend with a 5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026May 1, 2026
How to read this metric
Higher spending indicates a strong focus on long-term growth and pipeline development.
Detailed definition
Costs incurred by the MedSurg segment for the research, development, and clinical testing of new medical devices and tec...
Peer comparison
Standard R&D investment metric for technology-driven medical device firms.
Metric ID:
bsx_segment_medsurg_research_and_development_expensesHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $108M | $108M | $108M | $108M | $107M | $107M | $107M | $107M | $107M | $114M | $113M | $128M | $121M | $120M | $128M | $138M | $127M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -0.9% | +0.0% | +0.0% | +0.0% | +0.0% | +6.5% | -0.9% | +13.3% | -5.5% | -0.8% | +6.7% | +7.8% | -8.0% |
| YoY Change | — | — | — | — | -0.9% | -0.9% | -0.9% | -0.9% | +0.0% | +6.5% | +5.6% | +19.6% | +13.1% | +5.3% | +13.3% | +7.8% | +5.0% |
Range$107M – $138M
CAGR+4.1%
Avg YoY Growth+5.6%
Median YoY Growth+5.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's medsurg — research and development expenses?
- Boston Scientific (BSX) reported medsurg — research and development expenses of $127M in Q1 2026.
- How has Boston Scientific's medsurg — research and development expenses changed year-over-year?
- Boston Scientific's medsurg — research and development expenses increased by 5.0% year-over-year, from $121M to $127M.
- What is the long-term trend for Boston Scientific's medsurg — research and development expenses?
- Over 3 years (2022 to 2025), Boston Scientific's medsurg — research and development expenses has grown at a 5.5% compound annual growth rate (CAGR), from $432M to $507M.
- What does medsurg — research and development expenses mean?
- The total investment in research and development for new products within the MedSurg segment.